| 書目名稱 | Idiopathic Pulmonary Fibrosis | | 副標(biāo)題 | Advances in Diagnost | | 編輯 | Hiroyuki Nakamura,Kazutetsu Aoshiba | | 視頻video | http://file.papertrans.cn/462/461072/461072.mp4 | | 概述 | Introducing new developments such as serum makers that are highly specific to IPF, the establishment of systematic diagnosis imaging and antifibrotic agent.Each chapter addresses key issues under disc | | 圖書封面 |  | | 描述 | From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop | | 出版日期 | Book 2016 | | 關(guān)鍵詞 | HRCT; IIP; IPF; KL-6; SP-A; SP-D | | 版次 | 1 | | doi | https://doi.org/10.1007/978-4-431-55582-7 | | isbn_softcover | 978-4-431-56281-8 | | isbn_ebook | 978-4-431-55582-7 | | copyright | Springer Japan 2016 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-25 03:34
發(fā)表于 2025-3-21 17:18:18
